Skip to main content

This Week in BMC Cancer: Nov 21, 2011


In BMC Cancer this week, researchers in the US and Spain report their characterization of a novel PTEN mutation in a breast cancer cell line. The team evaluated PTEN expression in several human breast carcinoma cell lines and were able to generate a novel mutation in the PTEN gene in the MDA-MB-453 cell line. The mutation alters the gene's sub-cellular distribution and could lead to a predisposition of breast epithelial cells to transform into cancer cells, the authors write. Tumor cells harboring this mutation, they add, may be less susceptible to chemotherapeutic agents.

Also in BMC Cancer this week, a team of South Korean researchers analyze the prognostic significance of systemic inflammation in response to first-line palliative chemotherapy in recurrent or metastatic gastric cancer patients. The team analyzed data from 402 patients with advanced gastric cancer who had received first-line chemotherapy from 2004 to 2009, and found that the presence of a systemic inflammatory response was significantly associated with shorter progression-free survival and overall survival.

And finally in BMC Cancer this week, researchers in the US, Singapore, and China report on clinicopathologic and gene expression parameters that can predict prognosis in patients with liver cancer. The team collected tumor and adjacent healthy liver tissue from 272 patients that received curative surgery for hepatocellular carcinoma. They found that disease prognosis was significantly associated with six clinicopathologic parameters, which partitioned the patients into good and poor prognosis groups, and that gene expression data further divided the patients into sub-groups. "Our predictive genes significantly overlap with previously published gene sets predictive of prognosis," the authors write. "Moreover, the predictive genes were enriched for genes that underwent normal-to-tumor gene network transformation." When applied separately, clinicopathologic parameters and gene expression were similar in their prognostic power, the team adds. But when combined, the two modalities had greatly increased power to predict prognosis.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.